Invention Grant
US08759348B2 Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
有权
使用4-（吡咯烷-1-基）喹啉化合物杀死临床潜在的微生物
- Patent Title: Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
- Patent Title (中): 使用4-（吡咯烷-1-基）喹啉化合物杀死临床潜在的微生物
-
Application No.: US12600470Application Date: 2008-05-16
-
Publication No.: US08759348B2Publication Date: 2014-06-24
- Inventor: Mandy Christine Beswick , Susan Mary Cramp , Yanmin Hu , Thomas David Pallin , Hazel Joan Dyke , Anthony Coates
- Applicant: Mandy Christine Beswick , Susan Mary Cramp , Yanmin Hu , Thomas David Pallin , Hazel Joan Dyke , Anthony Coates
- Applicant Address: GB Selby
- Assignee: Helperby Therapeutics Limited
- Current Assignee: Helperby Therapeutics Limited
- Current Assignee Address: GB Selby
- Agency: Steptoe & Johnson LLP
- Priority: GB0709489.9 20070517; GB0807591.3 20080425
- International Application: PCT/GB2008/001694 WO 20080516
- International Announcement: WO2008/142384 WO 20081127
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; A61K31/497 ; A61K31/501 ; C07D401/14 ; C07D403/14 ; C07D401/04
Abstract:
There is provided the use of compounds of formula wherein R1, R2, R3 and E have meanings given in the description, for the preparation of a medicament for killing clinically latent microorganisms. There is also provided the use of compounds of formula I for treating microbial infections, as well as certain compounds of formula (I) per se.
Public/Granted literature
- US20100305065A1 USE OF 4-(PYRROLIDIN-1-YL)QUINOLINE COMPOUNDS TO KILL CLINICALLY LATENT MICROORGANISMS Public/Granted day:2010-12-02
Information query
IPC分类:
